211 related articles for article (PubMed ID: 6461996)
1. Danazol has progestin-like actions on the human endometrium.
Kokko E; Jänne O; Kauppila A; Rönnberg L; Vihko R
Acta Endocrinol (Copenh); 1982 Apr; 99(4):588-93. PubMed ID: 6461996
[TBL] [Abstract][Full Text] [Related]
2. Effects of tamoxifen, medroxyprogesterone acetate, and their combination on human endometrial estrogen and progestin receptor concentrations, 17 beta-hydroxysteroid dehydrogenase activity, and serum hormone concentrations.
Kokko E; Jänne O; Kauppila A; Vihko R
Am J Obstet Gynecol; 1982 Jun; 143(4):382-8. PubMed ID: 6211985
[No Abstract] [Full Text] [Related]
3. Short-term effects of danazol and medroxyprogesterone acetate on cytosol and nuclear estrogen and progestin receptors, 17 beta-hydroxysteroid dehydrogenase activity, histopathology, and ultrastructure of human endometrial adenocarcinoma.
Kauppila A; Isotalo H; Kivinen S; Stenbäck F; Vihko R
Int J Cancer; 1985 Feb; 35(2):157-63. PubMed ID: 3156097
[TBL] [Abstract][Full Text] [Related]
4. Steroidal regulation of endometriosis tissue: lack of induction of 17 beta-hydroxysteroid dehydrogenase activity by progesterone, medroxyprogesterone acetate, or danazol.
Vierikko P; Kauppila A; Rönnberg L; Vihko R
Fertil Steril; 1985 Feb; 43(2):218-24. PubMed ID: 2981748
[TBL] [Abstract][Full Text] [Related]
5. Danazol binding to steroid receptors in human uterine endometrium.
Tamaya T; Wada K; Fujimoto J; Yamada T; Okada H
Fertil Steril; 1984 May; 41(5):732-5. PubMed ID: 6714450
[TBL] [Abstract][Full Text] [Related]
6. Progestin-like effects of danazol on rabbit uterus.
Kokko E
Endocrinology; 1983 Mar; 112(3):1110-4. PubMed ID: 6822205
[TBL] [Abstract][Full Text] [Related]
7. Short-term effects of tamoxifen, medroxyprogesterone acetate, and their combination on receptor kinetics and 17 beta-hydroxysteroid dehydrogenase in human endometrium.
Neumannová M; Kauppila A; Kivinen S; Vihko R
Obstet Gynecol; 1985 Nov; 66(5):695-700. PubMed ID: 2997680
[TBL] [Abstract][Full Text] [Related]
8. The biochemistry of human endometrium after two regimens of postcoital contraception: a dl-norgestrel/ethinylestradiol combination or danazol.
Kubba AA; White JO; Guillebaud J; Elder MG
Fertil Steril; 1986 Apr; 45(4):512-6. PubMed ID: 3956767
[TBL] [Abstract][Full Text] [Related]
9. Return of ovulation following a single injection of depo-medroxyprogesterone acetate: a pharmacokinetic and pharmacodynamic study.
Lan PT; Aedo AR; Landgren BM; Johannisson E; Diczfalusy E
Contraception; 1984 Jan; 29(1):1-18. PubMed ID: 6234145
[TBL] [Abstract][Full Text] [Related]
10. Estradiol and progesterone receptor concentrations and 17 beta-hydroxysteroid-dehydrogenase activity in estrogen-progestin stimulated endometrium of women with gonadal dysgenesis.
Lübbert H; Pollow K; Römmler A; Hammerstein J
J Steroid Biochem; 1982 Aug; 17(2):143-8. PubMed ID: 6810024
[TBL] [Abstract][Full Text] [Related]
11. Cytosol estrogen and progestin receptor concentrations and 17 beta-hydroxysteroid dehydrogenase activities in the endometrium and endometriotic tissue. Effects of hormonal treatment.
Kauppila A; Vierikko P; Isotalo H; Rönnberg L; Vihko R
Acta Obstet Gynecol Scand Suppl; 1984; 123():45-9. PubMed ID: 6093422
[TBL] [Abstract][Full Text] [Related]
12. Investigation of Danazol as a contraceptive agent.
Wentz AC; Jones GS; Sapp KC
Contraception; 1976 May; 13(5):619-30. PubMed ID: 1261264
[TBL] [Abstract][Full Text] [Related]
13. Estrogen and progestin regulation of the progesterone receptor concentration in human endometrium.
Kreitmann B; Bugat R; Bayard F
J Clin Endocrinol Metab; 1979 Dec; 49(6):926-9. PubMed ID: 92478
[TBL] [Abstract][Full Text] [Related]
14. Hormonal inhibition of the endometrium for resectoscopic endometrial ablation.
Brooks PG; Serden SP; Davos I
Am J Obstet Gynecol; 1991 Jun; 164(6 Pt 1):1601-6; discussion 1606-8. PubMed ID: 1904683
[TBL] [Abstract][Full Text] [Related]
15. Cytoplasmic and nuclear estradiol and progesterone receptors in human endometrium.
Bayard F; Damilano S; Robel P; Baulieu EE
J Clin Endocrinol Metab; 1978 Apr; 46(4):635-48. PubMed ID: 755048
[TBL] [Abstract][Full Text] [Related]
16. Assessment of oestrogen and progestin effects on epithelium and stroma from pre- and postmenopausal endometria.
King RJ; Lane G; Siddle N; Taylor RW; Townsend PT; Whitehead MI
J Steroid Biochem; 1981 Dec; 15():175-81. PubMed ID: 7339244
[TBL] [Abstract][Full Text] [Related]
17. Interruption of endometrial maturation without hormonal changes by an antiprogesterone during the first half of luteal phase of the menstrual cycle: a contraceptive potential.
Greene KE; Kettel LM; Yen SS
Fertil Steril; 1992 Aug; 58(2):338-43. PubMed ID: 1633899
[TBL] [Abstract][Full Text] [Related]
18. Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system.
Critchley HO; Wang H; Kelly RW; Gebbie AE; Glasier AF
Hum Reprod; 1998 May; 13(5):1210-7. PubMed ID: 9647549
[TBL] [Abstract][Full Text] [Related]
19. Sequential regimen of the antiprogesterone RU486 and synthetic progestin for contraception.
Kekkonen R; Lähteenmäki P; Luukkainen T; Tuominen J
Fertil Steril; 1993 Oct; 60(4):610-5. PubMed ID: 8405512
[TBL] [Abstract][Full Text] [Related]
20. Preclinical evaluation of norgestimate, a progestin with minimal androgenic activity.
Phillips A; Hahn DW; McGuire JL
Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1191-6. PubMed ID: 1415445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
